Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Variants in FAM13A are associated with chronic obstructive pulmonary disease

Abstract

We performed a genome-wide association study for chronic obstructive pulmonary disease (COPD) in three population cohorts, including 2,940 cases and 1,380 controls who were current or former smokers with normal lung function. We identified a new susceptibility locus at 4q22.1 in FAM13A and replicated this association in one case-control group (n = 1,006) and two family-based cohorts (n = 3,808) (rs7671167, combined P = 1.2 × 10−11, combined odds ratio in case-control studies 0.76, 95% confidence interval 0.69–0.83).

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Regional association plot for signal at the FAM13A locus.

References

  1. Rabe, K.F. et al. Am. J. Respir. Crit. Care Med. 176, 532–555 (2007).

    Article  Google Scholar 

  2. Silverman, E.K. Proc. Am. Thorac. Soc. 3, 405–408 (2006).

    Article  CAS  Google Scholar 

  3. Pillai, S.G. et al. PLoS Genet. 5, e1000421 (2009).

    Article  Google Scholar 

  4. Fishman, A. et al. N. Engl. J. Med. 348, 2059–2073 (2003).

    Article  Google Scholar 

  5. Bell, B. et al. Aging Hum. Dev. 3, 5–17 (1972).

    Article  Google Scholar 

  6. Wilk, J.B. et al. PLoS Genet. 5, e1000429 (2009).

    Article  Google Scholar 

  7. Vestbo, J. et al. Eur. Respir. J. 31, 869–873 (2008).

    Article  CAS  Google Scholar 

  8. Cohen, M. et al. Genomics 84, 374–383 (2004).

    Article  CAS  Google Scholar 

  9. Chi, J.T. et al. PLoS Med. 3, e47 (2006).

    Article  Google Scholar 

  10. Wade, K.C. et al. Am. J. Respir. Cell Mol. Biol. 34, 727–737 (2006).

    Article  CAS  Google Scholar 

  11. Wright, J.M. et al. Am. J. Respir. Cell Mol. Biol. 35, 327–336 (2006).

    Article  CAS  Google Scholar 

  12. Hancock, D.B. et al. Nat. Genet. 42, 45–52 (2010).

    Article  CAS  Google Scholar 

  13. Repapi, E. et al. Nat. Genet. 42, 36–44 (2010).

    Article  CAS  Google Scholar 

  14. Wellcome Trust Case Control Consortium. Nature 447, 661–678 (2007).

  15. Thorgeirsson, T.E. et al. Nature 452, 638–642 (2008).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by US National Institutes of Health (NIH) grants R01 HL075478, R01 HL084323, P01 HL083069, U01 HL089856 (E.K.S.), K12HL089990 (M.H.C) and U01 HL089897 (J.D.C.). The National Emphysema Treatment Trial was supported by the National Heart, Lung, and Blood Institute, the Centers for Medicare and Medicaid Services and the Agency for Healthcare Research and Quality. The Normative Aging Study is supported by the Cooperative Studies Program/ERIC of the US Department of Veterans Affairs and is a component of the Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC). The Norway cohort, the ECLIPSE study (Clinicaltrials.gov identifier NCT00292552; GSK Code SCO104960) and the ICGN study are funded by GlaxoSmithKline. Further acknowledgments are given in the Supplementary Note.

Author information

Authors and Affiliations

Authors

Contributions

Study design: E.K.S., M.H.C., A.A.L., D.S., S.G.P., X.K., W.H.A., R.T.-S., D.A.L., P.B., A.G., J.R.M., T.H.B., E.A.R., B.J.M., J.E.H., J.D.C., C.P.H. and D.L.D. Sample collection and phenotyping: A.A.L., D.S., S.G.P., X.K., W.H.A., R.T.-S., D.A.L., P.B., A.G., E.A.R., B.J.M., J.D.C., E.K.S. Genotyping: N.B., B.J.K., M.H.C., S.G.P., X.K. Informatics: M.H.C., J.S.S., J.P.Z., B.J.K., N.B. Statistical analysis: M.H.C., C.L., S.W., E.K.S. Manuscript writing: M.H.C., G.M.H., E.K.S. All authors reviewed and approved the manuscript.

Corresponding author

Correspondence to Edwin K Silverman.

Ethics declarations

Competing interests

E.K.S. has received grant support and consulting and speaker's fees from GlaxoSmithKline, consulting and speaker's fees from Astra-Zeneca and speaker's fees from Bayer and Wyeth. D.A.L. has received grant support, lecture fees and consultancy fees from GlaxoSmithKline. S.G.P, X.Q.K., W.H.A. and R.M.T. are employees of GlaxoSmithKline.

Supplementary information

Supplementary Text and Figures

Supplementary Methods, Supplementary Note, Supplementary Figures 1–3 and Supplementary Tables 1–4 (PDF 466 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cho, M., Boutaoui, N., Klanderman, B. et al. Variants in FAM13A are associated with chronic obstructive pulmonary disease. Nat Genet 42, 200–202 (2010). https://doi.org/10.1038/ng.535

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ng.535

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing